Nutex Health Inc.
For the period ended Dec 31, 2025. Filed Mar 5, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
(a)The following documents are filed as part of this Report:
Management Report on Internal Control Over Financial Reporting
Reports of Independent Registered Public Accounting Firm (PCAOB ID Number 248 and 688)
Consolidated Balance Sheets as of December 31, 2025 and 2024
Consolidated Statements of Operations for the Years Ended December 31, 2025, 2024 and 2023
Consolidated Statements of Equity for the Years Ended December 31, 2025, 2024 and 2023
Consolidated Statements of Cash Flows for the Years Ended December 31, 2025, 2024 and 2023
Notes to Consolidated Financial Statements
(b)Exhibits:
| Incorporated by Reference(File No. 001-41346) | ||||
|---|---|---|---|---|
| Exhibit No | Description | Form | Exhibit | File Date |
| 2.1 | Agreement and Plan of Merger dated as of November 23, 2021 among Clinigence Holdings, Inc., Nutex Acquisition LLC, Nutex Health Holdco LLC, Micro Hospital Holding LLC (solely for the purposes of certain Sections ), Nutex Health LLC (solely for the purposes of certain Sections) and Thomas T. Vo in his capacity as the Nutex Representative | 8-K | 99.1 | Nov. 24, 2021 |
| 2.2 | Form of Contribution Agreement (Under Construction Hospitals) as of November 23, 2021 by and among Nutex Health Holdco LLC and the owners listed on the signature pages thereto | 10-Q | 2.5 | Aug. 22, 2022 |
| 2.3 | Form of Contribution Agreement (Ramping Hospitals) as of November 23, 2021 by and among Nutex Health Holdco LLC and the owners listed on the signature pages thereto | 10-Q | 2.6 | Aug. 22, 2022 |
| 2.4 | Form of Contribution Agreement (Mature Hospitals) as of November 23, 2021 by and among Nutex Health Holdco LLC and the owners listed on the signature pages thereto | 10-Q | 2.7 | Aug. 22, 2022 |
| 3.1 | Second Amended and Restated Certificate of Incorporation | 8-K | 3.1 | July 5, 2023 |
| 3.2 | Second Amended and Restated Bylaws | 8-K | 3.2 | Apr. 4, 2022 |
| 3.3 | Amendment to Second Amended and Restated Certificate of Incorporation | 8-K | 3.1 | Apr. 11, 2024 |
| 3.4 | Amendment No. 2 to Second Amended and Restated Certificate of Incorporation | 8-K | 3.1 | July 5, 2024 |
| 4.1 | Form of Warrant November 18, 2019 | 8-K | 10.3 | Nov. 22. 2019 |
| 4.2 | 2019 Omnibus Equity Incentive Plan | S-8 (333-267710) | 10.2 | Sep. 30, 2022 |
| 4.3* | Description of Capital Stock | |||
| 4.4 | Registration Rights Agreement dated as of April 1, 2022 by and among Nutex Health Inc. and the stockholders of Nutex Health Holdco LLC set forth on Schedule A thereto | Schedule 13D | 99.2 | Apr. 11, 2022 |
| 4.5 | Amendment No. 1 dated as of July 1, 2022 to Registration Rights Agreement dated as of April 1, 2022 | 10-Q | 4.9 | Aug. 22, 2022 |
| 4.6 | Amended and Restated Nutex Health Inc. 2023 Equity Incentive Plan | Schedule 14A | Appendix A | May 19, 2023 |
| 4.7* | Amendment No. 1 to the Amended and Restated Nutex Health Inc. 2023 Equity Incentive Plan | |||
| 4.8 | Nutex Health Inc. 2023 Employee Stock Purchase Plan | 8-K | 10.2 | July 5, 2023 |
| 4.9 | Form of Stock Purchase Warrant expiring December 31, 2029 | 10-K | 4.13 | Mar. 29, 2024 |
| 4.10 | Form of Common Stock Purchase Warrant | 8-K | 4.1 | Jan. 24, 2024 |
| 4.11* | Amendment to Stock Purchase Warrant dated December 16, 2025 | |||
| 10.1 | Master Services Agreement dated as of February 25, 2021 by and between AHA Management, Inc. and AHPIPA | 8-K | 2.2 | Mar. 2, 2021 |
| 10.2* | Board of Directors Agreement | |||
| 10.3 | Employment Agreement between Thomas T. Vo and Clinigence Holdings, Inc. (to be renamed Nutex Health Inc.) dated as of April 1, 2022 | 8-K | 10.1 | Apr. 4, 2022 |
| 10.4 | Employment Agreement between Warren Hosseinion and Clinigence Health Holdings, Inc. (to be renamed Nutex Health Inc.) dated April 1, 2022 | 8-K | 10.2 | Apr. 4, 2022 |
| 10.5 | Employment Agreement, dated as of June 8, 2022, between the Company and Jon Bates. | 8-K | 10.2 | Jun. 10, 2022 |
| 10.6 | Form of Commercial Lease Agreement (Hospital Entities) including Parent Guarantee (Nutex Health Inc.) | 10-Q | 10.11 | Aug. 22, 2022 |
| 10.7 | Form of Construction Loan Agreement (Hospital Entities) including Personal Guarantee (Related Parties) | 10-Q | 10.12 | Aug. 22, 2022 |
| 10.8 | Pre-Paid Advance Agreement by and between YA II PN, Ltd., a Cayman Islands exempt limited partnership and Nutex Health Inc., dated April 11, 2023. | 8-K | 10.1 | Apr. 12, 2023 |
| 10.9 | Form of Notice of Grant and Stock Option Agreement | 10-K | 10.25 | Mar. 29, 2024 |
| 10.10 | Form of Restricted Stock Award Agreement | 10-K | 10.26 | Mar. 29, 2024 |
| 10.11 | Form of Restricted Unit Award Agreement | 10-K | 10.27 | Mar. 29, 2024 |
| 10.12 | Termination of Pre-Paid Advance Agreement dated February 8, 2024 | 10-K | 10.28 | Mar. 29, 2024 |
| 10.13 | Addendum to Employment Agreement between Nutex Health Inc. and Thomas T. Vo dated as of February 8, 2024 | 8-K | 10.1 | Feb. 9, 2024 |
| 10.14 | Employment Agreement between Nutex Health Inc. and Michael Chang dated as of September 9, 2022 | 10-K | 10.30 | Mar. 29, 2024 |
| 10.15 | Amendment to Employment Agreement between Nutex Health Inc. and Michael Chang dated as of January 31, 2024 | 10-K | 10.31 | Mar. 29, 2024 |
| 10.16 | Employment Agreement, executed as of September 16, 2025 between the Company and Wesley Bamburg | 8-K | 10.1 | Sep. 22, 2025 |
| 10.17* | Payment Dispute Resolution Services Agreement between Nutex Health Inc. and HaloMD dated as of May 1, 2024 | |||
| 19.1 | Securities Trading Policy | 10-K | 19.1 | Mar. 31, 2025 |
| 21.1* | List of Subsidiaries | |||
| 23.1* | Consent of Grant Thornton | |||
| 23.2* | Consent of Marcum LLP | |||
| 31.1* | Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||
| 31.2* | Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||
| 32.1** | Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||
| 32.2** | Certification of the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||
| 97.1 | Nutex Health Inc. Compensation Recovery Policy | 10-K | 97.1 | Mar. 31, 2025 |
| 101.INS* | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||
| 101.SCH* | XBRL Taxonomy Extension Schema Document. | |||
| 101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document. | |||
| 101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document. | |||
| 101.LAB* | XBRL Taxonomy Extension Label Linkbase Document. | |||
| 101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document. | |||
| 104 | Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||
*Filed herewith
**Furnished herewith. This exhibit shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.